
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 707.45 |
| High | 715.00 |
| Low | 701.00 |
| Prev Close | 707.45 |
| Volume | 7,200 |
| VWAP(₹) | 708.18 |
| PE Ratio(x) | 14.75 |
| EPS - TTM(₹) | 47.91 |
| MCap(₹ Cr.) | 2,056.78 |
| MCap Rank | 14 |
| PB Ratio(x) | 1.69 |
| Div Yield(%) | 0.28 |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 1,098.00 |
| 52W Low(₹) | 518.60 |
| MCap/Sales | 0.72 |
| Beta(1 Month) | 2.49 |
| BV/Share(₹) | 419.42 |
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 7.65% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Increase in Cash from Investing
Company has used Rs 86.47 cr for investing activities which is an YoY increase of 129.25%. (Source: Consolidated Financials)Insecticide Ind Share Price Update
Insecticides (India) Ltd. share price moved down by -0.09% from its previous close of Rs 707.45. Insecticides (India) Ltd. stock last traded price is 706.85
| Share Price | Value |
|---|---|
| Today/Current/Last | 706.85 |
| Previous Day | 707.45 |
Found Insights useful?
| 1 Day | -0.09% |
| 1 Month | 0.81% |
| 3 Months | 15.89% |
| 1 Year | -19.12% |
| 3 Years | 56.09% |
| 5 Years | 67.49% |
1 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | - | - | - | - |
| Buy | 1 | 1 | 1 | 1 |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 1 | 1 | 1 | 1 |
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Income | 430.99 | 385.68 | 640.21 | 694.84 | 361.78 |
| Total Income Growth (%) | 11.75 | -39.76 | -7.86 | 92.06 | 1.09 |
| Total Expenses | 410.10 | 366.94 | 557.55 | 613.86 | 337.62 |
| Total Expenses Growth (%) | 11.76 | -34.19 | -9.17 | 81.82 | 0.96 |
| EBIT | 20.89 | 18.74 | 82.66 | 80.98 | 24.16 |
| EBIT Growth (%) | 11.46 | -77.33 | 2.07 | 235.17 | 2.96 |
| Profit after Tax (PAT) | 11.71 | 10.49 | 59.11 | 58.11 | 13.89 |
| PAT Growth (%) | 11.65 | -82.26 | 1.72 | 318.29 | -20.01 |
| EBIT Margin (%) | 4.85 | 4.86 | 12.91 | 11.65 | 6.68 |
| Net Profit Margin (%) | 2.72 | 2.72 | 9.23 | 8.36 | 3.84 |
| Basic EPS (₹) | 4.02 | 3.60 | 20.31 | 19.97 | 4.77 |
All figures in Rs Cr, unless mentioned otherwise
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 7.65% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | 2,000.18 | 1,898.15 | 1,713.50 | 1,696.31 | 1,396.20 |
| Total Assets Growth (%) | 5.38 | 10.78 | 1.01 | 21.50 | -2.09 |
| Total Liabilities | 779.77 | 813.55 | 699.96 | 778.02 | 526.59 |
| Total Liabilities Growth (%) | -4.15 | 16.23 | -10.03 | 47.75 | -13.04 |
| Total Equity | 1,220.41 | 1,084.59 | 1,013.53 | 918.29 | 869.61 |
| Total Equity Growth (%) | 12.52 | 7.01 | 10.37 | 5.60 | 6.00 |
| Current Ratio (x) | 1.96 | 1.83 | 1.90 | 1.62 | 1.97 |
| Total Debt to Equity (x) | 0.12 | 0.09 | 0.08 | 0.17 | 0.06 |
| Contingent Liabilities | 0.00 | 0.11 | 111.96 | 106.25 | 225.12 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 100.25 | 93.46 | 183.67 | -10.63 | 134.85 |
| Net Cash used in Investing Activities | -86.47 | -37.72 | -42.99 | -86.40 | 9.31 |
| Net Cash flow from Financing Activities | 17.53 | -61.09 | -98.06 | 79.68 | -114.64 |
| Net Cash Flow | 31.30 | -5.36 | 42.62 | -17.35 | 29.52 |
| Closing Cash & Cash Equivalent | 87.23 | 55.93 | 61.25 | 18.63 | 35.98 |
| Closing Cash & Cash Equivalent Growth (%) | 55.96 | -8.69 | 228.79 | -48.23 | 456.70 |
| Total Debt/ CFO (x) | 1.44 | 1.07 | 0.45 | -14.96 | 0.37 |
All figures in Rs Cr, unless mentioned otherwise
Cash from Operations vs PAT
Operating cash flow of Rs 100.25 cr is 0.72 times compared to the reported net profit of Rs 139.41 cr. (Source: Consolidated Financials)Increase in Cash from Investing
Company has used Rs 86.47 cr for investing activities which is an YoY increase of 129.25%. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Return on Equity (%) | 11.42 | 13.09 | 10.09 | 6.88 | 12.35 |
| Return on Capital Employed (%) | 16.13 | 17.76 | 13.50 | 10.35 | 16.61 |
| Return on Assets (%) | 6.96 | 7.48 | 5.97 | 3.72 | 7.69 |
| Interest Coverage Ratio (x) | 14.14 | 33.25 | 15.80 | 9.16 | 26.22 |
| Asset Turnover Ratio (x) | 1.10 | 1.11 | 1.15 | 1.16 | 1.07 |
| Price to Earnings (x) | 11.10 | 12.14 | 14.14 | 21.88 | 11.27 |
| Price to Book (x) | 1.27 | 1.59 | 1.43 | 1.51 | 1.39 |
| EV/EBITDA (x) | 6.72 | 7.73 | 8.54 | 12.36 | 7.04 |
| EBITDA Margin (%) | 11.15 | 11.41 | 8.74 | 6.83 | 11.56 |
Found Financials useful?
No Data Available
No Data Available
| R1 | - | Pivot - | S1 | - |
| R2 | - | S2 | - | |
| R3 | - | S3 | - |
| 5 Days | 14 Days | 28 Days |
| - | - | - |
Choose from Peers
Choose from Stocks
MF Ownership as on 30 April 2026
182.27
Amount Invested (in Cr.)
0.48%
% of AUM
0.00
% Change (MoM basis)
0.00
Amount Invested (in Cr.)
0.00283015%
% of AUM
4.35
% Change (MoM basis)
Board Meeting
Audited Results
Apr 16, 2026
Board Meeting
Quarterly Results, Dividend & Others
Jan 14, 2026
Interim Dividend
20%
Jan 14, 2026
| Announced on | Meeting on |
| Apr 16, 2026 | May 28, 2026 |
| Audited Results | |
| Jan 14, 2026 | Jan 30, 2026 |
| Quarterly Results, Dividend & Others | |
| Sep 26, 2025 | Nov 12, 2025 |
| Quarterly Results & Others | |
| Jun 26, 2025 | Aug 13, 2025 |
| Quarterly Results | |
| Mar 24, 2025 | May 28, 2025 |
| Audited Results & Others | |
| Announced on | Ex-Date | Dividend% |
| Jan 14, 2026 | Feb 06, 2026 | 20% |
| Jul 24, 2024 | Aug 23, 2024 | 20% |
| Sep 29, 2023 | Nov 10, 2023 | 30% |
| Feb 03, 2023 | Feb 24, 2023 | 30% |
| May 26, 2022 | Sep 15, 2022 | 30% |
| Announced on | Ex-Date |
| Aug 20, 2022 | Sep 30, 2022 |
| Bonus Ratio: 1 share(s) for every 2 shares held | |
| Oct 30, 2014 | Apr 16, 2015 |
| Bonus Ratio: 1 share(s) for every 2 shares held | |
No Data Available
No Data Available
| Announced on | Meeting on |
| Jul 16, 2025 | Aug 12, 2025 |
| - | |
| Jul 18, 2024 | Aug 12, 2024 |
| - | |
| Aug 10, 2023 | Sep 23, 2023 |
| - | |
| Jun 22, 2021 | Sep 09, 2021 |
| - | |
| Jun 25, 2020 | Sep 04, 2020 |
| Book closure from Aug 28, 2020 to Sep 4, 2020 | |
Insecticides (India) Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 2,056.78 Crore) operating in Pesticides/Agro Chemicals sector.
Industry
Key Indices Listed On
BSE SmallCap, BSE Commodities, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500
Address
401-402, Lusa Tower,Azadpur Commercial Complex,Delhi, Delhi - 110033
Hari Chand Aggarwal
Chairman & Wholetime DirectorRajesh Kumar Aggarwal
Managing DirectorAnil Kumar Goyal
Whole Time DirectorNikunj Aggarwal
Whole Time DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.